s6y
Company name or ticker
Search
Jasper Therapeutics, Inc.
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Filed
Wednesday, May 26, 2021
Accession number
0001213900-21-029337
Documents
FORM 425
425
On sec.gov
Filing index
All files
Complete submission text
SGML header